Cargando…

Propylamin in Rheumatism

Detalles Bibliográficos
Autor principal:	Gaston, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	1871
Materias:	Miscellaneous
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9448233/ https://www.ncbi.nlm.nih.gov/pubmed/36666489

Ejemplares similares

Propylamine
Publicado: (1873)

Unimolecular Decomposition Reactions of Propylamine and Protonated Propylamine
por: Almatarneh, Mansour H., et al.
Publicado: (2019)

Propylamine–borane
por: Gainsford, Graeme J., et al.
Publicado: (2009)

Rheumatism
Publicado: (1869)

The Rheumatism of Kalmia
por: Lilienthal, S.
Publicado: (1891)

Computational study of the unimolecular and bimolecular decomposition mechanisms of propylamine
por: Almatarneh, Mansour H., et al.
Publicado: (2020)

Salicylate of Soda in Rheumatism
por: Clark, A.
Publicado: (1876)

On the Treatment of Acute Rheumatism
por: Inman, Thomas
Publicado: (1864)

Salicylic Acid in Rheumatism
Publicado: (1878)

Salicylic Acid in Acute Rheumatism
por: Perrin, T. A.
Publicado: (1877)

New Treatment of Acute Rheumatism
Publicado: (1868)

Bee-Virus for Acute Rheumatism
por: Wood, James
Publicado: (1894)

On the Application of Chloroform in Neuralgia and Muscular Rheumatism
por: De Frenelle, Dupuy
Publicado: (1866)

Rheumatism, and a Plea for Higher Potencies
por: Rushmore, Edward
Publicado: (1888)

On Sesquichloride of Iron as a Prophylactic of Acute Rheumatism
por: Anstie,
Publicado: (1871)

Treatment of Tendinous Rheumatism by the External Employment of Sulphur
Publicado: (1864)

On the Use of Veratra in the Acute Articular Rheumatism of Children
Publicado: (1863)

Trousseau’s Syrup of Lime in the Treatment of Acute Rheumatism
Publicado: (1867)

Cases of Rheumatic Fever Treated by Salicylic Acid
por: Kebble, Alfred
Publicado: (1878)

Alteration of Sensibility in Articular Rheumatism, and the Electro-Therapeutical Treatment of the Disease
Publicado: (1876)

Mechanism of activation of the prokaryotic channel ELIC by propylamine: A single-channel study
por: Marabelli, Alessandro, et al.
Publicado: (2015)

Chromatin interactions reveal novel gene targets for drug repositioning in rheumatic diseases
por: Martin, Paul, et al.
Publicado: (2019)

Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey
por: Mehta, Bella, et al.
Publicado: (2020)

Mechanisms and Kinetics for Sorption of CO(2) on Bicontinuous Mesoporous Silica Modified with n-Propylamine
por: Bacsik, Zoltán, et al.
Publicado: (2011)

Synthesis and Spectrosopic Identification of Hybrid 3-(Triethoxysilyl)propylamine Phosphine Ruthenium(II) Complexes
por: Warad, Ismail, et al.
Publicado: (2010)

Isobutylamine, Isopropylamine, sec-Butylamine, Propylamine, Hexylamine, Pentylamine and 2-Methylbutylamine (Flavoring Substances)
Publicado: (2019)

Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry
por: Glintborg, Bente, et al.
Publicado: (2021)

Person-focused care for young people with rheumatic and musculoskeletal diseases: young rheumatologists' and EULAR Young PARE perspectives
por: Alunno, Alessia, et al.
Publicado: (2017)

Fatigue in patients with rheumatic and musculoskeletal diseases: a scoping review on definitions, measurement instruments, determinants, consequences and interventions
por: Beckers, Esther, et al.
Publicado: (2023)

Treatment of Nervous and Rheumatic Affections by Static Electricity
Publicado: (1874)

Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Gwinnutt, James M, et al.
Publicado: (2022)

Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases
por: Marques, Andréa, et al.
Publicado: (2022)

Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases
por: Fragoulis, George E, et al.
Publicado: (2022)

[N,N-Bis(diphenylphosphino)propylamine-κ(2) P,P′]dichloridoplatinum(II)
por: Cloete, Nicoline, et al.
Publicado: (2009)

Rich Collection of n-Propylamine and Isopropylamine Conformers: Rotational Fingerprints and State-of-the-Art Quantum Chemical Investigation
por: Melosso, Mattia, et al.
Publicado: (2020)

[N,N-Bis(diphenylphosphino)propylamine-κ(2) P,P]bromidotricarbonylrhenium(I)
por: Schutte, Marietjie, et al.
Publicado: (2009)

Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group
por: Ursini, Francesco, et al.
Publicado: (2023)

Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs
por: Gwinnutt, James M, et al.
Publicado: (2022)

Association between inactivated influenza vaccine and primary care consultations for autoimmune rheumatic disease flares: a self-controlled case series study using data from the Clinical Practice Research Datalink
por: Nakafero, Georgina, et al.
Publicado: (2019)

Bis(di-n-propylamine-κN)bis(tri-tert-butoxysilanethiolato-κS)chromium(II)
por: Ciborska, Anna, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_1gesbbadmi3qgebq2jivti283k